Do the authors have any information on recurrent presentations with atypical chest pain? In clinical practice, coronary angiography or revascularisation are often performed for patients with recurrent presentations with chest pain with normal troponin values. Are there any data on subsequent coronary angiography during follow-up?
On page 9 of the results, can the authors comment on the reason that 4 patients received revascularisation but did not have MI or UAP?
REVIEWER
Edd Carlton Emergency Department, North Bristol NHS Trust, UK I have published several papers in the field. I have undertaken research supported by Abbott diagnostics for related analyses.
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GENERAL COMMENTS
The authors report findings from a multicentre observational study which evaluates the clinical characteristics and prognosis of patients with non-specific chest pain who have been assessed using highsensitivity troponin assays. Whilst the data set is interesting and the manuscript has potential I feel there are some issues that require addressing. MAJOR 1. The manuscript is a little confused when it comes to the reporting of results particularly around gender. Much of the analysis is gender based and the results are reported according to gender. However, there is no mention of gender in the introduction or explanation of why you have chosen to undertake the analysis in this way. Furthermore, there is much evidence to support the use of genderspecific cut-points for the hs-cTnI assay but you have not used these or commented on them. This is a critical limitation if you continue to report your results by gender.
2. Within your clinical outcomes you use Unstable angina. This has significant limitations as it is often a subjective diagnosis. There is likely to be significant bias in reporting this as an outcome in a cohort selected as non-specific chest pain.
3. It is critical to include within your discussion the highly influential paper around non specific chest pain recently published in the BMJ (Prognosis of undiagnosed chest pain: linked electronic health record cohort study by Jordan et al.) . Your study appears to contradict this work and some explanation/discussion of this is required. I appreciate that you had probably undertaken the bulk of work on this manuscript prior to that work being published. Please leave your comments for the authors below Comment: The authors present a prospective multicentre cohort study from 6 hospitals in Denmark of patients presenting to the emergency department with chest pain with no other cause identified and a negative hsTn. They report a low incidence of cardiac related endpoints at 12 months (1.9%). Risk factors of male gender, BMI>25, previous known CAD, HTN, cholesterol, diabetes and statin use were associated with the clinical endpoints. The article is well written and easy to follow.
Response: Thank you.
Comment: The main novelty of the paper appears to be analysis of risk factors for subsequent cardiac events. It is not surprising that the factors identified: male gender, BMI >25, previous CAD/vascular disease, HTN, cholesterol, diabetes etc were predictive. These are the identical factors that would be predictors in the general population without chest pain presentation. Can the authors comment on how identification of these in patients with troponin negative chest pain would alter clinical management in the emergency department? Do the authors suggest that in patients with multiple factors and no troponin elevation be further evaluated?
Response: Yes we do believe that patients with multiple risk factors would benefit from further investigations. It would have been desireable to perform a prognostic regression with multiple risk factors. However with these few events, the strength of such would have been very weak. However in an another study (not yet published but submitted with revision), where we did a CT scan without contract on NSCP patients , the few endpoints were found in patients with multiple risk factors.
Comment: Many emergency departments organise outpatient functional testing for patients with troponin negative chest pain. This allows further risk stratification of patients, epsecially those in whom cardiovascular risk factors may be present. The authors should provide details of outpatient further evaluation and the results of these tests in the article.
Response: We agree that this would be interesting knowledge. However, we excluded patients who were referred for coronary angiography from index contact and hence we cannot provide full information on the outpatient follow-up.
Comment: Do the authors have any information on recurrent presentations with atypical chest pain?
In clinical practice, coronary angiography or revascularisation are often performed for patients with recurrent presentations with chest pain with normal troponin values. Are there any data on subsequent coronary angiography during follow-up?
Response: We did not include recurrent chest pain as an outcome in this study and therefor do not have this information available. We only have information on the revascularisations during follow-up.
Comment: On page 9 of the results, can the authors comment on the reason that 4 patients received revascularisation but did not have MI or UAP?
Response: The revascularisations cover acute and non-acute procedures. Thereby also patients referred for coronary angiography and subsequent percutaneous intervention from outpatient clinics and not solely admissions related revascularization (MI and UAP).
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Please leave your comments for the authors below Comment: The authors report findings from a multicentre observational study which evaluates the clinical characteristics and prognosis of patients with non-specific chest pain who have been assessed using high-sensitivity troponin assays. Whilst the data set is interesting and the manuscript has potential I feel there are some issues that require addressing.
Response: Thank you, we have tried to address your concerns beneath. MAJOR 1. The manuscript is a little confused when it comes to the reporting of results particularly around gender. Much of the analysis is gender based and the results are reported according to gender. However, there is no mention of gender in the introduction or explanation of why you have chosen to undertake the analysis in this way. Furthermore, there is much evidence to support the use of gender-specific cut-points for the hs-cTnI assay but you have not used these or commented on them. This is a critical limitation if you continue to report your results by gender.
Response: We agree, and we have changed the results section so it no longer report results by gender.
2. Within your clinical outcomes you use Unstable angina. This has significant limitations as it is often a subjective diagnosis. There is likely to be significant bias in reporting this as an outcome in a cohort selected as non-specific chest pain. We believe that there are still patients fulfilling the diagnosis of Unstable angina with typical angina at rest and with crescendo and some of them do also have ECG changes. Without troponin change which will differentiate them from NSCP patients.
Response: We do agree, that some patients can be misclassified and that with highly sensitive troponins more patients are diagnosed with NSTEMI instead of unstable Angina as studies has shown. We have included this point in our limitation.
3. It is critical to include within your discussion the highly influential paper around non-specific chest pain recently published in the BMJ (Prognosis of undiagnosed chest pain: linked electronic health record cohort study by Jordan et al.) . Your study appears to contradict this work and some explanation/discussion of this is required. I appreciate that you had probably undertaken the bulk of work on this manuscript prior to that work being published.
Response: Thank you for this input. We have included Jordan el als. Article in our discussion section. The design and setting we believe is different from our study and these have been discussed in this section.
4. A key discussion point is around NSCP and its diagnosis. You are relly testing diagnostic error, ie do these patients really have NSCP or have the treating clinicians got it wrong. It would be really useful (since you state you collected this data) to provide information on the nature/symptoms of pain to demonstrate that you cohort does in fact have NSCP.
Response: In this study we included patients with all kinds of chest pain, and a normal troponin and with the discharge diagnosis codes of NSCP: DR072 (precordial chest pains) ,DR073 (other chest pains), DZ034 (observation for myocardial infarction) and DZ035(observation for coronary disease). We chose to exclude patients with coronary angiography during index admission as we believe that these patients were more likely to been suspected for unstable angina pectoris. We have added this to the method section.
5. The manuscript is fairly lengthy and you should aim to reduce to 3000 words to maintain reader interest. I suspect you could cut a couple of hundred words from the discussion by being a little more focussed.
Response: We have reduced the article length as recommend. MINOR 1. Introduction, it is not clear how reference 1 reports the 14-17% outcome rates, I suspect there are better references available.
Response: References and statement has been changed accordingly.
2. Intro: You state 0.6-0.8% of NSCP patients have MACE within 30 days. This sounds fine to me and is probably an acceptable miss rate. I would therefore question you assertion that this is a "professional challenge"
